Center on Democracy, Development, and the Rule of Law
Center for International Security and Cooperation
Center on Food Security and the Environment
Stanford Health Policy
The Europe Center
Walter H. Shorenstein Asia-Pacific Research Center
Program on Energy and Sustainable Development
Rural Education Action Program
Stanford Program on International and Cross-Cultural Education
Inter-University Center for Japanese Language Studies
Ford Dorsey Program in International Policy Studies
Center for Innovation in Global Health
Stanford Center at Peking University
About CISAC
Mailing List
@StanfordCISAC
Facebook
CISAC News
Share on Facebook
Share on Twitter
Bookmark via Google
Share on Google+February 8, 2007
The Biotech Bubble: Why Stem-Cell Research Won't Make States Rich
CHP/PCOR in the news: Slate Magazine on February 6, 2007CHP/PCOR fellow Laurence Baker, a co-author of a recent study on stem cell research, was quoted in a Slate article on conflicting studies on the amount of revenue that stem cell research might generate for the states. Baker's research suggests that stem cell research would "generate state revenues and health care savings of $6.4 to $12.6 billion over 30 years," turning a $1 billion profit for California after accounting for state bonds used to fund research and bond interest payments. The analysis, entitled "Economic Impact Analysis: Proposition 71 - California Stem Cell Research and Cures" is a report commission by Californians for Stem Cell Research and Cures.
- » Slate Magazine: The Biotech Bubble
- » Lawrence Baker: Economic Impact Analysis of Proposition 71 - California Stem Cell Research and Cures
